Patents by Inventor Sanghyeon OH

Sanghyeon OH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRANSFORMED IMMUNE CELLS INDUCING CHEMOTAXIS TOWARDS HETEROGENEOUS IMMUNE CELLS
    Publication number: 20230382968
    Abstract: Immune cells expressing IL-7, CCL19, or a combination thereof, and a composition containing the immune cells, which is useful for preventing or treating cancer or infectious diseases are disclosed. A method for preventing or treating cancer or infectious diseases, which include administering a therapeutically effective amount of single type of immune cells, specifically natural killer cells, is also disclosed. Complementary immune responses between the patient's endogenous T cells and injected natural killer cells exhibit multifaceted and synergistic therapeutic effects. Co-administration of T cells and the immune cells other than T cells, specifically natural killer cells, also significantly improves therapeutic effects by allowing these heterogeneous cell populations to act in a lesion-concentrated manner.
    Type: Application
    Filed: October 28, 2021
    Publication date: November 30, 2023
    Applicant: TSD LIFE SCIENCES CO., LTD.
    Inventors: Ki Doo CHOI, Dohyun SON, Milim LEE, Sanghyeon OH